Cargando…
Computational analysis of mRNA expression profiles identifies a novel triple-biomarker model as prognostic predictor of stage II and III colorectal adenocarcinoma patients
INTRODUCTION: Although remarkable progress has been made to determine the prognosis of patients with colorectal cancer (CRC), it is inadequate to identify the subset of high-risk TNM stage II and stage III patients that have a high potential of developing tumor recurrence and may experience death. I...
Autores principales: | Cheng, Xiankui, Hu, Meilin, Chen, Chuancui, Hou, Dongsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118290/ https://www.ncbi.nlm.nih.gov/pubmed/30214289 http://dx.doi.org/10.2147/CMAR.S170502 |
Ejemplares similares
-
Serum miRNA expression profile as a prognostic biomarker of stage II/III colorectal adenocarcinoma
por: Li, Jialu, et al.
Publicado: (2015) -
Prognostic Factors Influencing Survival in Stage II and Stage III Colorectal Cancer Patients
por: Alkader, Mohammad S, et al.
Publicado: (2023) -
Regulatory activity based risk model identifies survival of stage II and III colorectal carcinoma
por: Liu, Gang, et al.
Publicado: (2017) -
Prognostic Factors for Post-Recurrence Survival in Stage II and III Colorectal Carcinoma Patients
por: Nikolic, Neda, et al.
Publicado: (2021) -
Pre-treatment platelet counts as a prognostic and predictive factor in stage II and III rectal adenocarcinoma
por: Steele, Morgan, et al.
Publicado: (2017)